Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Epilepsy Drugs Market by Generation Type (First Generation Drugs, Second Generation Drugs, Third Generation Drugs), Anti-Epileptics Drugs Type (Narrow-Spectrum AEDs, Broad-Spectrum AEDs), Distribution Channel (Hospital Pharmacy, Pharmacy Stores, and Others), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A6650
Buy Now
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Epilepsy Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Generation Type
6.1 First Generation Drugs
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Phenytoin
6.1.2.2 Carbamazepine
6.1.2.3 Oxcarbazepine
6.1.2.4 Valproate
6.1.2.5 Ethosuximide
6.1.2.6 Primidone
6.1.2.7 Phenobarbital
6.1.3 Market Forecast
6.2 Second Generation Drugs
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Levetiracetam
6.2.2.2 Lamotrigine
6.2.2.3 Topiramate
6.2.2.4 Pregabalin
6.2.2.5 Rufinamide
6.2.2.6 Zonisamide
6.2.3 Market Forecast
6.3 Third Generation Drugs
6.3.1 Market Trends
6.3.2 Key Segments
6.3.2.1 Lacosamide
6.3.2.2 Perampanel
6.3.2.3 Eslicarbazepine Acetate
6.3.2.4 Ezogabine/Retigabine
6.3.3 Market Forecast
7 Market Breakup by Anti-Epileptics Drugs Type
7.1 Narrow-Spectrum AEDs
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Broad-Spectrum AEDs
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Hospital Pharmacy
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Pharmacy Stores
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
10.1 Overview
10.2 Drivers
10.3 Restraints
10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Alkem Laboratories Limited
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Bausch Health Companies Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Eisai Co. Ltd.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 GSK plc
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 H. Lundbeck A/S
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Jazz Pharmaceuticals plc
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Novartis AG
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Pfizer Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Sunovion Pharmaceuticals Inc. (Sumitomo Dainippon Pharma Co. Ltd.)
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 SWOT Analysis
14.3.11 UCB S.A.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report
List of Figures
Figure 1: Global: Epilepsy Drugs Market: Major Drivers and Challenges
Figure 2: Global: Epilepsy Drugs Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Epilepsy Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Epilepsy Drugs Market: Breakup by Generation Type (in %), 2023
Figure 5: Global: Epilepsy Drugs Market: Breakup by Anti-Epileptics Drugs Type (in %), 2023
Figure 6: Global: Epilepsy Drugs Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: Epilepsy Drugs Market: Breakup by Region (in %), 2023
Figure 8: Global: Epilepsy Drugs (First Generation Drugs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Epilepsy Drugs (First Generation Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Epilepsy Drugs (Second Generation Drugs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Epilepsy Drugs (Second Generation Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Epilepsy Drugs (Third Generation Drugs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Epilepsy Drugs (Third Generation Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Epilepsy Drugs (Narrow-Spectrum AEDs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Epilepsy Drugs (Narrow-Spectrum AEDs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Epilepsy Drugs (Broad-Spectrum AEDs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Epilepsy Drugs (Broad-Spectrum AEDs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Epilepsy Drugs (Hospital Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Epilepsy Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Epilepsy Drugs (Pharmacy Stores) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Epilepsy Drugs (Pharmacy Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Epilepsy Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Epilepsy Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: North America: Epilepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: North America: Epilepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: United States: Epilepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: United States: Epilepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Canada: Epilepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Canada: Epilepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Asia-Pacific: Epilepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Asia-Pacific: Epilepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: China: Epilepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: China: Epilepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Japan: Epilepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Japan: Epilepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: India: Epilepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: India: Epilepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: South Korea: Epilepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: South Korea: Epilepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Australia: Epilepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Australia: Epilepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Indonesia: Epilepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Indonesia: Epilepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Others: Epilepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Others: Epilepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Europe: Epilepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Europe: Epilepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Germany: Epilepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Germany: Epilepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: France: Epilepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: France: Epilepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: United Kingdom: Epilepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: United Kingdom: Epilepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Italy: Epilepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Italy: Epilepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Spain: Epilepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Spain: Epilepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Russia: Epilepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Russia: Epilepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Others: Epilepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Others: Epilepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Latin America: Epilepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Latin America: Epilepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Brazil: Epilepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Brazil: Epilepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Mexico: Epilepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Mexico: Epilepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Others: Epilepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Others: Epilepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Middle East and Africa: Epilepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Middle East and Africa: Epilepsy Drugs Market: Breakup by Country (in %), 2023
Figure 72: Middle East and Africa: Epilepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Global: Epilepsy Drugs Industry: Drivers, Restraints, and Opportunities
Figure 74: Global: Epilepsy Drugs Industry: Value Chain Analysis
Figure 75: Global: Epilepsy Drugs Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Epilepsy Drugs Market: Key Industry Highlights, 2023 & 2032
Table 2: Global: Epilepsy Drugs Market Forecast: Breakup by Generation Type (in Million US$), 2024-2032
Table 3: Global: Epilepsy Drugs Market Forecast: Breakup by Anti-Epileptics Drugs Type (in Million US$), 2024-2032
Table 4: Global: Epilepsy Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 5: Global: Epilepsy Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Epilepsy Drugs Market: Competitive Structure
Table 7: Global: Epilepsy Drugs Market: Key Players
Purchase options
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More